Really great news.
Concretes even more how effective Bisantrene is. This derisks the company even more for me, and imagine others would be looking at it the same way. The more data like this we get, the more stable and less speculative an investment it is into RAC.
Great job to management as always, and great job in the delivery of the announcement, it reads clearly and succinctly for those who do not come from a med / science background. Thank you
The market is still asleep but with time they'll realise what bisantrene can do.
Ann: Positive Early Preclinical Ovarian Cancer Results, page-26
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.50 |
Change
-0.025(1.64%) |
Mkt cap ! $253.8M | |||
| Open | High | Low | Value | Volume |
| $1.53 | $1.55 | $1.49 | $104.8K | 69.66K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 650 | $1.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.50 | 1002 | 1 |
View Market Depth
| Last trade - 13.59pm 20/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |